FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2021826449> ?p ?o ?g. }

• W2021826449 endingPage "849" @default.
• W2021826449 startingPage "841" @default.
• W2021826449 abstract "Connective tissue growth factor (CTGF) is involved in the development and progression of kidney diseases, including diabetic nephropathy and kidney fibrosis, but also may have a role in mesangial repair after injury. It is unknown whether, in the general population, urinary CTGF levels are associated with a decrease in estimated glomerular filtration rate (eGFR) to <60 mL/min/1.73 m(2) (ie, development of chronic kidney disease [CKD] stage 3).Nested case-control.100 cases of incident CKD stage 3 and 100 age-and sex-matched controls in the Framingham Heart Study; 141 cases and 135 age-, sex-, and race-matched controls in the Atherosclerosis Risk in Communities (ARIC) Study. Controls had eGFR ≥60 mL/min/1.73 m(2) at follow-up in both studies.Urinary CTGF concentrations.Incident CKD stage 3, defined as eGFR <60 mL/min/1.73 m(2).Stored urine samples from Framingham Heart Study and ARIC were measured for CTGF. Covariates were obtained from Framingham Heart Study and ARIC participant examinations.In the Framingham Heart Study, the median baseline urinary CTGF concentration was lower in cases (1.35 ng/mL) than controls (2.35 ng/mL; paired t test, P < 0.0001). The multivariable-adjusted OR for incident CKD stage 3 was 0.33 (95% CI, 0.17-0.64; P < 0.001) per 1-standard deviation in log urinary CTGF level after adjustment for CKD risk factors, baseline eGFR, and baseline log urinary albumin-creatinine ratio, with similar results in participants without diabetes (n = 184). Results were not materially different when urinary CTGF level was indexed to urinary creatinine level (multivariable-adjusted OR, 0.34; 95% CI, 0.21-0.56; P < 0.001). A similar, but nonsignificant, trend of risk of incident CKD stage 3 with lower baseline urinary CTGF concentration was observed in an independent case-control study conducted in the ARIC Study, with the strongest results observed in participants free of diabetes. This inverse relationship was robust in meta-analysis of both the overall and diabetes-free groups.Observational study; causality cannot be inferred.Lower urinary CTGF concentrations precede the onset of CKD stage 3 in the general population. Further work is required to fully characterize how CTGF level influences risk of CKD." @default.
• W2021826449 created "2016-06-24" @default.
• W2021826449 creator A5002731748 @default.
• W2021826449 creator A5004859885 @default.
• W2021826449 creator A5013798210 @default.
• W2021826449 creator A5035036076 @default.
• W2021826449 creator A5047227825 @default.
• W2021826449 creator A5056798958 @default.
• W2021826449 creator A5071554578 @default.
• W2021826449 date "2011-06-01" @default.
• W2021826449 modified "2023-10-02" @default.
• W2021826449 title "Lower Urinary Connective Tissue Growth Factor Levels and Incident CKD Stage 3 in the General Population" @default.
• W2021826449 cites W1964941505 @default.
• W2021826449 cites W1981997645 @default.
• W2021826449 cites W1982010552 @default.
• W2021826449 cites W1982601765 @default.
• W2021826449 cites W1992283514 @default.
• W2021826449 cites W1996387976 @default.
• W2021826449 cites W1998539941 @default.
• W2021826449 cites W2003574534 @default.
• W2021826449 cites W2004242414 @default.
• W2021826449 cites W2005263621 @default.
• W2021826449 cites W2007088839 @default.
• W2021826449 cites W2008930082 @default.
• W2021826449 cites W2009407308 @default.
• W2021826449 cites W2011196230 @default.
• W2021826449 cites W2017089487 @default.
• W2021826449 cites W2027693573 @default.
• W2021826449 cites W2028820951 @default.
• W2021826449 cites W2038262102 @default.
• W2021826449 cites W2039359299 @default.
• W2021826449 cites W203951001 @default.
• W2021826449 cites W2045516356 @default.
• W2021826449 cites W2047764356 @default.
• W2021826449 cites W2055864845 @default.
• W2021826449 cites W2061523453 @default.
• W2021826449 cites W2061582963 @default.
• W2021826449 cites W2064535158 @default.
• W2021826449 cites W2071177404 @default.
• W2021826449 cites W2075093222 @default.
• W2021826449 cites W2082447097 @default.
• W2021826449 cites W2087920840 @default.
• W2021826449 cites W2094404475 @default.
• W2021826449 cites W2094588898 @default.
• W2021826449 cites W2102633875 @default.
• W2021826449 cites W2106173480 @default.
• W2021826449 cites W2110997620 @default.
• W2021826449 cites W2115931410 @default.
• W2021826449 cites W2116323280 @default.
• W2021826449 cites W2122603733 @default.
• W2021826449 cites W2132803823 @default.
• W2021826449 cites W2132862752 @default.
• W2021826449 cites W2138670606 @default.
• W2021826449 cites W2141913464 @default.
• W2021826449 cites W2148861103 @default.
• W2021826449 cites W2154186340 @default.
• W2021826449 cites W2158599500 @default.
• W2021826449 cites W2160751100 @default.
• W2021826449 cites W2161561361 @default.
• W2021826449 cites W2162351890 @default.
• W2021826449 cites W2211287272 @default.
• W2021826449 cites W2329019805 @default.
• W2021826449 cites W4234944895 @default.
• W2021826449 cites W4242416368 @default.
• W2021826449 doi "https://doi.org/10.1053/j.ajkd.2010.11.022" @default.
• W2021826449 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3100386" @default.
• W2021826449 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21292366" @default.
• W2021826449 hasPublicationYear "2011" @default.
• W2021826449 type Work @default.
• W2021826449 sameAs 2021826449 @default.
• W2021826449 citedByCount "18" @default.
• W2021826449 countsByYear W20218264492012 @default.
• W2021826449 countsByYear W20218264492013 @default.
• W2021826449 countsByYear W20218264492014 @default.
• W2021826449 countsByYear W20218264492015 @default.
• W2021826449 countsByYear W20218264492016 @default.
• W2021826449 countsByYear W20218264492017 @default.
• W2021826449 countsByYear W20218264492018 @default.
• W2021826449 countsByYear W20218264492019 @default.
• W2021826449 countsByYear W20218264492023 @default.
• W2021826449 crossrefType "journal-article" @default.
• W2021826449 hasAuthorship W2021826449A5002731748 @default.
• W2021826449 hasAuthorship W2021826449A5004859885 @default.
• W2021826449 hasAuthorship W2021826449A5013798210 @default.
• W2021826449 hasAuthorship W2021826449A5035036076 @default.
• W2021826449 hasAuthorship W2021826449A5047227825 @default.
• W2021826449 hasAuthorship W2021826449A5056798958 @default.
• W2021826449 hasAuthorship W2021826449A5071554578 @default.
• W2021826449 hasBestOaLocation W20218264492 @default.
• W2021826449 hasConcept C111815664 @default.
• W2021826449 hasConcept C11783203 @default.
• W2021826449 hasConcept C126322002 @default.
• W2021826449 hasConcept C126894567 @default.
• W2021826449 hasConcept C134018914 @default.
• W2021826449 hasConcept C159641895 @default.
• W2021826449 hasConcept C170493617 @default.
• W2021826449 hasConcept C207103383 @default.
• W2021826449 hasConcept C2775960820 @default.

• next